Cerebras Surges in IPO Debut Challenging Nvidias AI Chip Dominance Gates Foundation Exits Microsoft as Ackman Loads Up Whats Wall Street Missing London Tube Strike Suspension Brings Relief to Commuters and Businesses Bond Market Signals Concerns Over Feds Inflation Response Under Warshs Leadership Canaccord Lowers Regeneron Price Target After Disappointing Phase 3 Trial Outcome Googles Homepage Overhaul A Tiny Design Change With Big Implications for Search and AI Chinas Crypto Crackdown A CatandMouse Game With Middlemen Novartis Raises FullYear Sales and Profit Guidance Amid Strong Operational Performance UK Welfare Reforms Needed as Benefits Spending Outpaces Youth Job Investment Warns Milburn The Human Cost of AI Wendy Liu Argues Against the Privatization of Intelligence by Big Tech CCNEP Q1 2026 Earnings EPS Beats Estimates Preferred Stock Shows Resilience MUSA Q1 2026 Earnings Strong EPS Beat Amid Challenging Retail Environment EDUC Q1 2026 Earnings Educational Development Corporation Reports Loss Amidst Unclear Revenue Picture BHFAN Q1 2026 Earnings EPS Misses Estimates as Operational Headwinds Weigh Liberty Media Corporation Series C Liberty Formula One FWONK Q4 2025 Earnings Modest EPS Miss Amidst Continued Formula One Growth SBGI Q1 2026 Earnings Strong EPS Surprise Amid a Shifting Media Landscape ARS Pharmaceuticals SPRY Gains Ground Testing Resistance at 893 After 4 Rally Social Commerce Partners Corporation Warrant SCPQW Rallies 13 Amid Renewed Interest LendingClub LC Slips 082 as Stock Tests Key Support at 1485 Cousins Properties CUZ Holds Steady as Support Level Attracts Buyers Key Technical Range in Focus Puma Biotechnology PBYI Edges Higher Amidst Key Support and Resistance Levels Taiwan Emerges as Key Flashpoint in TrumpXi Talks as US Arms Sales Loom Consensus Cloud Solutions Inc CCSI Q1 2026 Earnings Solid EPS Beat Lifts Sentiment Despite Flat Revenue Picture Donegal Group Inc DGICA Shows Modest Decline as Trading Holds Within Key Range Textron Q1 2026 Earnings Strong EPS Surprise Drives Modest Stock Gain MRNA Q1 2026 Earnings NarrowerThanExpected Loss Lifts Shares Disc Medicine Q1 2026 Earnings Narrowed Loss Beats Estimates as Biotech Advances Hematology Pipeline MX Q1 2026 Earnings EPS Beat by 5146 but Stock Declines 67 CVI Q1 2026 Earnings EPS Misses by Over 210 Amid Refining Headwinds TRP Q1 2026 Earnings NearMiss on EPS with Modest Stock Uptick DJCO Q4 2025 Earnings Strong EPS of 3061 Highlights Profitability Amidst No Revenue Disclosure